Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment
Weiran Cao, Xue Zhang, Rui Li, Zijie Li, An Lu, F. Richard Yu, Lu Sun, Jiancheng Wang, Zhiyu Wang, Huining He
Topics & Concepts
FOLFOXRegimenCancer researchOxaliplatinPharmacologyMedicineColorectal cancerChemistryCancerInternal medicineCancer Immunotherapy and BiomarkersNanoplatforms for cancer theranosticsImmunotherapy and Immune Responses